Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTH1R | Q03431 | 10/20 | 0.66 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.66 |
| ▸ | IL23R | Q5VWK5 | 5/20 | 0.62 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.61 |
| ▸ | GHSR | Q92847 | 2/20 | 0.58 |
| ▸ | NPY2R | P49146 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Penetratin SCHEMBL29450548 | 0.97 | KEAP1 (0.64) | PTH1RKEAP1IL23RRXFP1GHSR | |
| SCHEMBL31749000 | 0.97 | PTH1R (0.63) | PTH1RKEAP1IL23RRXFP1GHSR | |
| SCHEMBL29710643 | 0.97 | PTH1R (0.65) | PTH1RKEAP1IL23RRXFP1GHSR | |
| SCHEMBL29350300 | 0.97 | PTH1R (0.64) | PTH1RKEAP1IL23RRXFP1GHSR | |
| SCHEMBL29429587 | 0.97 | PTH1R (0.64) | PTH1RKEAP1IL23RRXFP1GHSR | |
| SCHEMBL30299196 | 0.95 | PTH1R (0.67) | PTH1RKEAP1IL23RRXFP1GHSR | |
| Kqikiwfqnkkmkwkk-Nh2 SCHEMBL31748869 | 0.95 | PTH1R (0.60) | PTH1RKEAP1IL23RRXFP1GHSR | |
| SCHEMBL30617122 | 0.94 | PTH1R (0.61) | PTH1RKEAP1IL23RGHSRNPY2R | |
| SCHEMBL31232534 | 0.93 | PTH1R (0.68) | PTH1RKEAP1IL23RRXFP1 | |
| SCHEMBL30002139 | 0.93 | PTH1R (0.63) | PTH1RKEAP1IL23RRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4588 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747274-A2 | PROTEIN-BASED DELIVERY SYSTEM | Beth Israel Deaconess Medical Center, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| CN-116493599-B | Preparation method of silver nanocubes | SOUTHEAST UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122060054-A | Nanometer antibody for resisting porcine delta coronavirus nucleocapsid protein, recombinant, preparation and application thereof | 四川大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122031717-A | Efficient stable high-biocompatibility nano delivery carrier and preparation method and application thereof | 广州墨羲科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026090590-A1 | NANOPARTICLE FORMULATIONS FOR THE DELIVERY OF DNA TO ADIPOSE TISSUE | Remedium Bio, Inc. (US) | 2026-04-30 | — | — | WO | claimed |
| WO-2026090123-A1 | METHODS AND COMPOSITIONS FOR MANAGING PESTS | UOVO INTERNATIONAL LLC (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260108469-A1 | COMPOSITIONS COMPRISING WATER INSOLUBLE DRUGS AND METHODS OF PRODUCING AND USING SAME | NANO GHOST LTD (IL) | 2026-04-23 | — | — | US | claimed |
| US-20260110698-A1 | METHODS FOR QUANTIFYING FRATAXIN ACTIVITY | LARIMAR THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | claimed |
| US-12590126-B2 | Compounds for selective disruption of protein-protein interactions | SYNTHEX, INC. (US) | 2026-03-31 | — | — | US | claimed |
| US-20260085302-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS | CONFLUENCE GENETICS, LLC (US) | 2026-03-26 | — | — | US | claimed |
| CN-114316014-A | Leader peptide for targeted inhibition of neuroblastoma cell growth, fusion peptide and application thereof | 江苏医药职业学院 | 2022-04-12 | — | — | CN | claimed |
| CN-114269359-A | Methods for making and using mesenchymal stem cell-derived secreted proteomes | 康巴乔有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-114262698-A | Leader peptide for targeted inhibition of MSI colorectal cancer cell growth, fusion peptide and application thereof | 江苏医药职业学院 | 2022-04-01 | — | — | CN | claimed |
| US-20220090066-A1 | CELL PENETRATING MOLECULE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-03-24 | — | — | US | claimed |
| EP-3600253-B1 | LIPOSOMAL COMPOSITIONS AND SOLID ORAL DOSAGE FORMS COMPRISING THE SAME | UNIV HEIDELBERG (DE) | 2022-03-16 | — | — | EP | claimed |
| CN-114181315-A | Endosome escape peptide and application thereof | 清华大学 | 2022-03-15 | — | — | CN | claimed |
| EP-3955730-A1 | EMBRYOGENESIS FACTORS FOR CELLULAR REPROGRAMMING OF A PLANT CELL | Pioneer Hi-Bred International, Inc. (US) | 2022-02-23 | — | — | EP | claimed |
| US-11253559-B2 | Oncolytic viruses targeting STAT3 | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2022-02-22 | — | — | US | claimed |
| WO-2022032353-A1 | RADIOPHARMACEUTICALS, USES THEREOF, AND METHODS FOR THE PRODUCTION THEREOF | Clarity Pharmaceuticals Ltd (AU) | 2022-02-17 | — | — | WO | claimed |
| CN-114007653-A | Drug delivery vehicle and pharmaceutical preparation using the same | 复旦大学 | 2022-02-01 | — | — | CN | claimed |